Brief: Sienna Biopharmaceuticals Qtrly Net Loss $0.67

Sienna Biopharmaceuticals

08/05/2019 22:03

May 8 (Reuters) - Sienna Biopharmaceuticals Inc  SNNA.O :
    * SIENNA BIOPHARMACEUTICALS REPORTS FIRST QUARTER 2019
FINANCIAL
RESULTS
    * QTRLY  NET LOSS, BASIC AND DILUTED $0.67
    * CASH BURN DURING THREE MONTHS ENDED MAR. 31, 2019 WAS
APPROXIMATELY $12.8 MILLION
    * SIENNA'S CASH AND CASH EQUIVALENTS AS OF MAR. 31, 2019
TOTALED
APPROXIMATELY $57.2 MILLION

Source text for Eikon:  ID:nGNXc7S7d4 
Further company coverage:  SNNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))